• QPS Taiwan Benefits
        • QPS Taiwan Staff
        • QPS US Benefits
        • QPS-US-Staff

 

 

 

 

QPS Pharmaceutical Services

QPS is a global GLP-compliant contract laboratory supporting drug discovery and development. Since 1995, we have provided high quality services to pharmaceutical and biotechnology clients worldwide. We provide industry-experienced scientists to manage your studies utilizing the latest technologies and state-of-the art instruments. Our four areas of expertise include:
 Bioanalysis [LC/MS/MS, ELISA, Hybridization-ELISA]
 Drug Metabolism and Pharmacokinetics (DMPK)
 Biomarkers (Protein/Biochemical markers, Genomic markers)
 Early clinical research

QPS-US LC/MS/MS bioanalysis services are supported by 33 tandem mass spectrometers including 25 Sciex API-4000's. QPS-Taiwan has 4 LC/MS/MS instruments for GLP studies. The QPS large molecule quantitation team offers ELISA and hybridization-ELISA for quantitative analysis of protein drugs, oligonucleotide-based drugs, immunogenicity testing, and cell-based assays.

QPS's IND-enabling ADME (Absorption, Distribution, Metabolism, and Excretion) package includes pharmacokinetics, protein binding, tissue distribution by Quantitation Whole-Body Autoradiography (QWBA) and microautoradiography, CYP450 and mass balance/excretion studies. We offer a full range of drug metabolism capabilities including metabolic stability, inhibition and ex vivo induction, reaction phenotyping, and metabolite profiling and identification.

QPS-US also provides rodent pharmacokinetics, protein binding, metabolic stability, and in vitro CYP450 inhibition as part of our discovery screen. QPS-Taiwan provides discovery dog pharmacokinetic studies.

The QPS biomarker team offers both full GLP compliant and CLIA type ELISA approaches to protein and biochemical marker analysis. Our molecular biology/genomic services include RNA/DNA isolation, SNP genotyping and genetic mutation analysis, quantitative RT-PCR, RNA expression analysis, and microarray gene expression profiling.

QPS's early phase clinical facility, Bio-Kinetic Clinical Applications, has over 240 beds and in the past 14 years has completed over 400 clinical trials involving nearly 11,000 study volunteers.

QPS-US Bioanalysis, DMPK, Biomarker, and AAALAC-accredited animal facilities are located in Newark, DE. The QPS-Taiwan facility is located in Taipei, Taiwan. Bio-Kinetic Clinical Application is headquartered in Springfield, MO.


No matter where in the world you are, QPS quality, service, and turnaround are within your reach.


 
©  QPS, L.L.C. . All rights reserved. 
Drug Discovery - Drug Development - Site Map